Myofibrillar proteins (MPs) were extracted from isolated and perfused rat hearts subjected to different periods of ischemia to investigate the occurrence of protein degradation and/or the association of cytosolic proteins with the myofibrillar pellet. A 23-kD band was detected by SDS-PAGE of MPs after 5 minutes of ischemia, with its density gradually increasing to a plateau after 20 minutes. Longer periods of ischemia were associated with the appearance of a 39-kD band. Irrespective of the duration of ischemia, both these bands persisted during reperfusion. A partial proteolytic degradation of troponin T (TnT) and troponin I (TnI) has been claimed to be responsible for the generation of these peptides. However, the N-terminal sequence of the 39-kD band was identical to that of GAPDH, whereas Edman sequencing after pepsin digestion showed that the 23 kD is alpha B-crystallin. The binding of the two cytosolic proteins to myofibrils was confirmed by immunofluorescence analysis on cryosections of ischemic hearts. In vitro studies showed that acidosis was sufficient to induce the binding of alpha B-crystallin, whereas the inhibition of ATP depletion prevented the binding of GAPDH. Thiol oxidation is unlikely to promote GAPDH binding, since perfusion with iodoacetate under aerobic conditions or treatment of homogenates with N-ethylmaleimide or diamide failed to induce GAPDH association with the myofibrils. These changes of the myofibrillar proteins could be considered as intracellular markers of the evolution of the ischemic damage. In addition, the binding of the 23-kD peptide might be involved in alterations of contractility.
Propionyl-L-carnitine, unlike L-carnitine, is known to improve myocardial function and metabolism altered during the course of ischemia-reperfusion. In this study, the effect of propionyl-L-carnitine has been compared with that of propionate and carnitine on the performance of rat hearts perfused with a glucose-containing medium either under normoxia, ischemia, or postischemic reperfusion. In the postischemic phase, contractile parameters were partially restored both in the control and in the propionate plus carnitine-treated hearts, were markedly impaired by propionate, and were fully recovered by propionyl-L-carnitine. In addition, propionyl-L-carnitine, but not propionate, reduced the functional decay of mitochondria prepared from the ischemic hearts. Even in normoxic conditions propionate, unlike propionyl-L-carnitine, caused a drastic reduction of free CoA and L-carnitine. The concomitant increase in lactate production and decrease in ATP content might be explained by the inhibition of pyruvate dehydrogenase caused by the accumulation of propionyl-CoA. Indeed, when pyruvate was the only oxidizable substrate, propionate induced a gradual decrease in developed pressure, which was largely prevented by L-carnitine. The protective effect of propionyl-L-carnitine may be a consequence of the anaplerotic utilization of propionate in the presence of an optimal amount of ATP and free L-carnitine.
In patients with intermittent claudication, assessment of plasma acetylcarnitine at rest and after exercise may be a means to select a target population for L-carnitine therapy.
When a 12-y-old girl suffering from isovaleric acidemia was treated with L-carnitine, there was a considerable increase in her blood and urine concentration of isovalerylcarnitine. When later the patient received an infusion of glycine in place of carnitine, isovalerylcarnitine reverted toward the low levels found in a normal subject. At the end of either treatment, erythrocyte calpain was measured and found to be decreased after carnitine therapy (140 versus 96 U/mg Hb with glycine or carnitine, respectively). Because we have previously shown that the activity of calpain isolated from erythrocytes was markedly modified by isovalerylcarnitine, the present results might be seen as the The intracellular nonlysosomal calcium-activated cysteine proteinases, commonly referred as calpains or calcium-activated proteinases, are present in virtually every eukaryotic cell type. On the basis of their sensitivity for c a 2 + , calpains have been subdivided into pcalpain and m-calpain, requiring 5-50 pM c a 2 + and 0.2-0.6 mM c a 2 + , respectively, for half maximum activity (1-5).We have recently found that IVC, a product of leucine catabolism, is a potent activator of the m-calpains, but not the p-calpains, isolated from various rat tissues (6,7).This activation comprises a 10-fold increase in the Km of calpain for Ca2+ together with an increase in the V, , above the values observed with the native enzyme at saturating c a 2 + concentrations. It is additional to the activation produced by adding phospholipid vesicles, showing that IVC could be acting as a highly selective activator of calpain, whether cytosolic or membrane bound. These effects were highly specific for the L-isomer of IVC. The D-isomer, other branched-chain acylcar-
Neonatal mastitis with possible abscess complication is relatively rare. The most common causal agent is Staphylococcus aureus. The paper describes the case of a newborn of 8 days of life, with fever and bilateral mastitis. The newborn was treated with antibiotic therapy with vancomicin and gentamicin and required the right breast surgical drainage for abscess complication. Culture of the pus yielded a pure growth of methicillin-resistant Staphylococcus aureus. The mother of the newborn presented with mastitis that developed a few days earlier. Complications of neonatal mastitis are rare nonetheless cellulitis, fasciitis, osteomyelitis, meningitis, brain abscess and sepsis have been reported. It is therefore essential to treat the mastitis of the newborn promptly and take into consideration the possible resistance of Staphylococcus that is the main etiological agent. Therefore, possible abscess complications need to be treated surgically.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.